HealthNotableConfirmed
5.9
FDA approves Roche and Eli Lilly Alzheimer's blood diagnostic test
Valor Econômico·US·3 days ago
Researchers at the University of Oulu have developed a wearable headband capable of measuring cerebrospinal fluid markers to detect Alzheimer's disease. The device, currently in trial use after 15 years of development, is nearing commercial readiness and could significantly alter early-stage diagnostic protocols.
Locations
Entities